CBD Improved Survival in Pancreatic Cancer Mice and Changed Gut Bacteria
CBD monotherapy extended survival in a mouse model of pancreatic cancer, accompanied by shifts in gut bacteria and bile acid metabolism, while THC and the THC-CBD combination did not improve outcomes.
Quick Facts
What This Study Found
Only CBD alone improved survival in KPC mice (a genetic model that mimics human pancreatic cancer). The THC-CBD combination, which synergistically killed pancreatic cancer cells in lab dishes, did not translate to survival benefits in living mice. CBD treatment was linked to changes in gut microbiota composition and bile acid profiles.
Key Numbers
CBD and THC synergistically reduced PDAC cell viability in vitro, but only CBD monotherapy improved survival in KPC mice. CBD effects on gut microbiota and bile acid profiles were distinct from those of THC alone or the combination.
How They Did This
Researchers tested THC and CBD individually and combined in PDAC cell lines and in KPC mice that spontaneously develop pancreatic cancer. Fecal microbiota was characterized by 16S rRNA gene sequencing, and bile acid profiling was performed using mass spectrometry on fecal, cecal, and plasma samples.
Why This Research Matters
Pancreatic cancer has among the worst survival rates of any cancer. The finding that CBD specifically altered gut bacteria and bile acid metabolism in surviving mice opens a new line of investigation into how cannabinoids might influence cancer outcomes through the gut-liver axis rather than direct tumor killing.
The Bigger Picture
This study challenges the common assumption that THC-CBD combinations are always better than either compound alone. The disconnect between cell culture results (where the combo worked best) and animal results (where only CBD helped) highlights the importance of studying whole-organism effects.
What This Study Doesn't Tell Us
KPC mice, while a strong model, do not perfectly replicate human pancreatic cancer. The study cannot determine whether the gut microbiota and bile acid changes caused the survival benefit or were simply correlated with it. Dosing and route of administration in mice may not translate directly to humans.
Questions This Raises
- ?Could targeting bile acid metabolism directly produce similar benefits?
- ?Why did the THC-CBD combination fail in vivo despite succeeding in vitro?
- ?Would CBD work alongside standard chemotherapy?
Trust & Context
- Key Stat:
- CBD alone improved survival; THC-CBD combo did not
- Evidence Grade:
- Animal study using a well-validated genetic mouse model of pancreatic cancer. Results are promising but require human clinical validation.
- Study Age:
- Published in 2025.
- Original Title:
- Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.
- Published In:
- International journal of molecular sciences, 26(16) (2025)
- Authors:
- Malhotra, Pratibha, Palanisamy, Ranjith, Panda, Arunima, Casari, Ilaria, Tirnitz-Parker, Janina E E, O'Gara, Fergal, Trengove, Robert, Ragunath, Krish, Caparros-Martin, Jose A, Falasca, Marco
- Database ID:
- RTHC-07028
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does this mean CBD treats pancreatic cancer?
Not yet. This is an animal study showing CBD extended survival in mice. Human clinical trials would be needed to determine if this effect translates to people.
Why might CBD work differently than THC in this context?
CBD and THC have different receptor profiles and metabolic effects. The study suggests CBD specifically alters bile acid metabolism and gut bacteria in ways that THC does not, which may be relevant to pancreatic cancer biology.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07028APA
Malhotra, Pratibha; Palanisamy, Ranjith; Panda, Arunima; Casari, Ilaria; Tirnitz-Parker, Janina E E; O'Gara, Fergal; Trengove, Robert; Ragunath, Krish; Caparros-Martin, Jose A; Falasca, Marco. (2025). Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.. International journal of molecular sciences, 26(16). https://doi.org/10.3390/ijms26167733
MLA
Malhotra, Pratibha, et al. "Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms26167733
RethinkTHC
RethinkTHC Research Database. "Cannabidiol Is Associated with Improved Survival in Pancreat..." RTHC-07028. Retrieved from https://rethinkthc.com/research/malhotra-2025-cannabidiol-is-associated-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.